Raymond James analyst Rahul Sarugaser is elevating his hopes on biotech company Ginkgo Bioworks (Ginkgo Bioworks Stock Quote, Charts, News, Analysts, Financials NYSE:DNA), saying the company impressed in its latest quarter. In an update to clients on Tuesday, Sarugaser retained his “Outperform 2” rating while raising his target price from $11.50 to $14.50, saying the […]
There’s a ton of upside to Akumin, says ClarusIt’s a good time to be buying US healthcare stock Akumin Inc (Akumin Stock Quote, Charts, News, Analysts, Financials NASDAQ:AKU), according to Clarus Securities analyst Noel Atkinson. Akumin is down about 68 per cent over the past 12 months, but a new cash injection has Atkinson raising his target price on Monday from $6.50 to […]